- Home
- COGT vs ASH Comparison
COGT vs ASH Comparison
Compare COGT & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- ASH
- Stock Information
- Founded
- COGT 2014
- ASH 1924
- Country
- COGT United States
- ASH United States
- Employees
- COGT N/A
- ASH N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- ASH Specialty Chemicals
- Sector
- COGT Health Care
- ASH Consumer Discretionary
- Exchange
- COGT Nasdaq
- ASH Nasdaq
- Market Cap
- COGT 2.3B
- ASH 2.3B
- IPO Year
- COGT 2018
- ASH N/A
- Fundamental
- Price
- COGT $16.30
- ASH $48.90
- Analyst Decision
- COGT Strong Buy
- ASH Buy
- Analyst Count
- COGT 12
- ASH 7
- Target Price
- COGT $22.00
- ASH $60.50
- AVG Volume (30 Days)
- COGT 2.4M
- ASH 638.3K
- Earning Date
- COGT 10-31-2025
- ASH 11-04-2025
- Dividend Yield
- COGT N/A
- ASH 3.39%
- EPS Growth
- COGT N/A
- ASH N/A
- EPS
- COGT N/A
- ASH N/A
- Revenue
- COGT N/A
- ASH $1,869,000,000.00
- Revenue This Year
- COGT N/A
- ASH N/A
- Revenue Next Year
- COGT N/A
- ASH $2.11
- P/E Ratio
- COGT N/A
- ASH N/A
- Revenue Growth
- COGT N/A
- ASH N/A
- 52 Week Low
- COGT $3.72
- ASH $45.21
- 52 Week High
- COGT $17.15
- ASH $88.89
- Technical
- Relative Strength Index (RSI)
- COGT 61.29
- ASH 44.80
- Support Level
- COGT $14.20
- ASH $49.54
- Resistance Level
- COGT $16.50
- ASH $50.85
- Average True Range (ATR)
- COGT 0.84
- ASH 1.16
- MACD
- COGT -0.07
- ASH 0.08
- Stochastic Oscillator
- COGT 71.19
- ASH 36.52
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.